EATG » CHMP recommends extension of therapeutic indication for Tivicay

CHMP recommends extension of therapeutic indication for Tivicay

At its December meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended an extension of the existing therapeutic indication for Tivicay.

Summary of opinion is available here.

Source:
EMA
News categories: HIV treatment, EMA/FDA